Not checked for notices yet.
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study
Harald Hampel, Coralie Williams, Adrien Etcheto and 6 more
Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2020
Cited by papers we hold 4
- Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future · 2023No notice
- Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease · 2023No notice
- An Update on Psychopharmacological Treatment of Autism Spectrum Disorder · 2022No notice
- Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.